Release Date: 03/10/13 13:50 Summary: Chairman's Address to Shareholders Price Sensitive: No Download Document 237.22KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%